baber/WOPTO huggingface dataset:
Patent AU-2014334837-B2 (AU)
Title: Fast response time in slump monitoring systems
Inventor: CHUN BYONG-WA
IPC: B28C7/12
Filed: 2014-09-30
Granted: 2017-10-05
Abstract: The present invention provides a fast response method and system wherein one or more comb-type polycarboxylate ether (PCE) polymers, having a cumulative adsorptivity coefficient in the range of 40%-75%, are employed as fluidizing admixtures dosed into concrete by and in automated slump monitoring and control systems which iteratively monitors and adjusts the slump of the concrete mix.
Patent AU-2014339000-B2 (AU)
Title: Sulfated polysaccharides for use in the treatment of cancer
Inventor: FABRICIUS HANS-AKE
IPC: A61K31/737
Filed: 2014-10-22
Granted: 2017-05-18
Abstract: The invention relates to a method for modulating the growth and/or proliferation of mammalian cells by modulating the physical interaction between platelets (thrombocytes) and the surface of the cells. The invention therefore relates to sulfated polysaccharides, preferably glycosaminoglycans, for use as a medicament for the inhibition of the physical interaction between the cell surface and platelets in the treatment of a medical disorder associated with unwanted cell growth and/or proliferation. In vitro methods for modulating the physical interaction between platelets (thrombocytes) and the surface of the cells in order to modulate cell proliferation are also encompassed by the invention. The invention therefore relates to the inhibition of the interaction between the cell surface and platelets for the inhibition of cell growth, and an enhancement of the interaction between platelets and the surface of the cell in order to enhance cell growth.
Patent AU-2014345599-B2 (AU)
Title: Salts of 1-(3-Methyl-2-oxo-2,3-dihydro-1,3-benzoxazol-6-yl)-2,4-dioxo-3-[(1R)- 4-(trifluormethyl)-2,3-dihydro-1H-inden-1-yl]-1,2,3,4-tetrahydropyrimidin-5-carboxylic acid
Inventor: OLENIK BRITTA
IPC: A61K31/513
Filed: 2014-11-05
Granted: 2019-02-14
Abstract: The invention relates to novel salts of 1-(3-methyl-2-oxo-2,3-dihydro-1,3-benzoxazol-6-yl)-2,4-dioxo-3-[(1R)- 4-(trifluormethyl)-2,3-dihydro-1H-inden-1-yl]-1,2,3,4-tetrahydropyrimidin-5-carboxylic acid of the formula (I), in particular amino acid salts such as lysine salt and alkali metal salts such as sodium salt and potassium salt, to a method for producing same, to medication containing same, and to the use thereof in treating diseases.
Patent AU-2014358968-B2 (AU)
Title: Cartridge for storing compressed air
Inventor: AGHILONE MARCELLO
IPC: F17C13/04
Filed: 2014-12-04
Granted: 2019-07-04
Abstract: The invention relates to a cartridge comprising a body (2) containing air, and a head (3) closing the body (2) and comprising a filling channel (10) which connects the outside of the cartridge to the body (2) and which comprises a non-return filling valve (11) preventing air from leaving the body (2). According to the invention, the head (3) comprises an inflation channel which connects the filling channel (10) to the body (2), which comprises a non-return inflation valve (32) preventing air from leaving the body (2), and wherein an inflation element (30) is mounted in a mobile manner, allowing the opening of the non-return inflation valve.
Patent AU-2014363888-B2 (AU)
Title: Multistage polymers and compositions thereof
Inventor: HARRIS PAUL J
IPC: C08F265/06
Filed: 2014-12-03
Granted: 2018-03-15
Abstract: Provided are multistage polymers that comprise (i) a first stagecomprising a first copolymer having a first theoretical T
Patent AU-2014377586-B2 (AU)
Title: Electric pulse generation systems using capacitive coupling
Inventor: CAIAFA ANTONIO
IPC: C12N13/00
Filed: 2014-11-20
Granted: 2020-05-28
Abstract: In accordance with the present disclosure, exposure of a sample to one or more electric pulses via capacitive coupling is described. In certain embodiments, the sample may be a biological sample to be treated or modified using the pulsed electric fields. In certain embodiments, the electric pulses may be delivered to a load using capacitive coupling. In other embodiments, the electric pulses may be bipolar pulses.
Patent AU-2015213324-B2 (AU)
Title: Pet food having modified waxy cassava starch
Inventor: HANCHETT DOUGLAS J
IPC: A23K20/163
Filed: 2015-08-13
Granted: 2019-01-17
Abstract: A pet food composition comprising a meat based material comprised of meat or meat by-products, and an aqueous phase comprised of an acetyl-substituted waxy cassava inhibited starch in an amount effective to thicken said aqueous phase is provided. 5 Also provided is a gravy for a pet food comprising an acetyl-substituted waxy cassava inhibited starch in an amount effective to thicken said composition and having a freeze/thaw stability greater than about 5 cycles as well as a method of feeding a canine or feline pet. Also provided is a gravy for a pet food comprised of a hydroxypropyl-substituted waxy cassava inhibited starch having less than about 10 2.5%, by weight of hydroxylpropyl substituents, in an amount effective to thicken said aqueous phase.
Patent AU-2015243054-B2 (AU)
Title: Regulated genetic suicide mechanism compositions and methods
Inventor: GIACALONE MATTHEW
IPC: C12N15/09
Filed: 2015-10-15
Granted: 2017-09-21
Abstract: Embodiments of the present invention relates to the incorporation and use of a regulated genetic suicide mechanism for use in the improved purification of biologies, including adjunct use in various eubacterial minicell production and purification methodologies. Described herein are high- yield eubacterial minicell-producing strains with genetic modifications that comprise a regulated genetic suicide mechanism that irreparably destroys the parent cell chromosome such that live parental cells in a culture can be functionally eliminated at any time during the course of a minicell production and purification run. Embodiments of the present invention also describe methods useful in the elimination of live parental cells during the production of other cell-based biologies. 2429677vl
Patent AU-2015243359-B2 (AU)
Title: Pharmaceutical composition against chronic bacterial infections
Inventor: MILLER STEFAN
IPC: A61P31/04
Filed: 2015-04-08
Granted: 2020-03-12
Abstract: The present invention relates to a polypeptide comprising a peptidoglycan hydrolase for use as a medicament for the treatment of chronic bacterial infections. The present invention further relates to a polypeptide comprising a peptidoglycan hydrolase comprising an endopeptidase, N-acetyl-muramoyl-L-alanine-amidase, N-acetyl-muramidase, N-acetyl-glucosaminidase and/or lytic transglycosylase.
Patent AU-2015314685-B2 (AU)
Title: Neural microphysiological systems and methods of using the same
Inventor: CURLEY JABE LOWRY
IPC: A61K35/30
Filed: 2015-09-14
Granted: 2021-02-25
Abstract: The present disclosure generally relates to a cell culturing system, and specifically to a three-dimensional cell culturing system for neuronal cells that promotes both structural and functional characteristics that mimic those of in vivo peripheral fibers, including cell myelination. Using a dual hydrogel construct and explants from neuronal cells, the present disclosure provides methods., devices, and systems for in vitro spatially-controlled, three-dimensional models that permit intra- and extra-cellular electrophysiological measurements and recordings. The three-dimensional hydrogel constructs allow for flexibility in incorporated cell types, geometric fabrication, and electrical manipulation, providing viable systems for culture, perturbation, and testing of biomimetic neural growth with physiologically-relevant results.
Patent AU-2015352524-B2 (AU)
Title: A statistical analytic method for the determination of the risk posed by file based content
Inventor: HUTTON SAM
IPC: G06F21/56
Filed: 2015-11-25
Granted: 2018-11-15
Abstract: A system and method for calculating a risk assessment for an electronic file is described. A database of checks, organized into categories, can be used to scan electronic files. The categories of checks can include weights assigned to them. An analyser can analyse electronic files using the checks. Issues identified by the analyser can be weighted using the weights to determine a risk assessment for the electronic file.
Patent AU-2015364481-B2 (AU)
Title: Steviol glycoside compounds, compositions for oral ingestion or use, and method for enhancing steviol glycoside solubility
Inventor: CARLSON TING LIU
IPC: C07H15/256
Filed: 2015-12-17
Granted: 2020-05-14
Abstract: Novel steviol glycoside compounds characterized by a first group of four glucopyranose residues attached via the number 13 carbon (C13) of the steviol moiety and a second group of two or three glucopyranose residues attached via the number 19 carbon (C19) of the steviol moiety are described, and exemplified by compounds 1 - 4. These compounds can be present in a composition with other steviol glycosides (e.g., Reb D and Reb M) to enhance their solubilities. Accordingly, the novel compounds can facilitate the preparation of aqueous compositions having a higher concentration of steviol glycosides. A steviol glycoside composition including one or more of compounds 1-4 can be used as a sweetener composition to sweeten other compositions (sweetenable compositions) such as foods, beverages, medicines, oral hygiene compositions, nutraceuticals, and the like.
Patent AU-2015371069-B2 (AU)
Title: Crystals of alanine N-acetic acid precursors, process to prepare them and their use
Inventor: BOUWMAN ALBERTUS JACOBUS MARIA
IPC: C07C255/25
Filed: 2015-12-21
Granted: 2019-08-22
Abstract: The present invention relates to alanine N-acetic acid precursors of formula (i) COOM-CH(CH3)-NH-(CH2CN), wherein M is hydrogen (alanine N-monoacetonitrile), or (ii) COOM-CH(CH3)-N-(CH2CN)2, wherein 0 to 50% of all M is sodium or potassium and 50 to 100% of all M is hydrogen (alanine Ν,Ν-diacetonitrile and its partial sodium or potassium salts) comprising L-alanine to D-alanine in a range of from 75:25 to 50:50 (L:D), or (iii) COOM-CH(CH3)-N-(CH2CONH2)2, wherein M is hydrogen (alanine Ν,Ν-diacetamide), in the form of crystals, and relates to a process to prepare these precursors and their use, especially to give MGMA or MGDA.
Patent AU-2015371319-B2 (AU)
Title: Methods and compositions for growth, storage, and use of bacterial preparations for wound and surface treatments
Inventor: DORSEY CALEB WILLIAM
IPC: C12N15/00
Filed: 2015-12-23
Granted: 2021-10-21
Abstract: The present invention relates to the field of bacteriology. In particular, the invention relates to methods and compositions for treatment and prevention of infection in wounds, and methods for producing and storing bacterial donor organisms for conjugation-based antibacterial agents. The present invention relates to the field of bacteriology and pharmacology. In particular, the invention relates to novel compositions (e.g., antimicrobial agents) and methods of using the same for treating tissue (e.g., lesions of the skin and other soft tissues) comprising the killing or altering (e.g., inhibiting) growth and virulence of populations of microorganisms.
Patent AU-2015395217-B2 (AU)
Title: Mount for solar panel
Inventor: TANAKA TATSUMI
IPC: H02S20/30
Filed: 2015-05-19
Granted: 2020-12-17
Abstract: A solar panel rack is provided such that an inclination angle of the solar panel can be easily and reliably changed without requiring cumbersome work. The solar panel rack 1 is provided with: a tilted support frame 2 having one pair of lateral members 21, 22 which are arranged in parallel with each other at different heights and extend in the horizontal direction and one pair of tilted members 23 which are bridged sideways between the lateral members and extend in parallel with each other while tilted to one side; a fixation/support member 3 for fixing and supporting the tilted support frame on an installation surface; a rectangular panel support member 5 to which a solar panel 7 is fixed; a support rod 4 which is disposed so as to extend between the tilted support frame and the panel support member and rotatably supports the panel support member; and one pair of stopper members 6f, 6r which are respectively disposed, in a rotatable manner at one end, on both rotating end sides of the panel support member, and which have recessed engagement parts 63f1, 63f2, 63r1, 63r2 for engaging, in a disengageable manner, with half portions of the outer peripheries of the lateral members from the rotating direction at positions corresponding to a predetermined tilt angle position of the panel support member.
Patent AU-2016201681-B2 (AU)
Title: A drug delivery system for the prevention of cerebral vasospasm
Inventor: MACDONALD R LOCH
IPC: A61K31/553
Filed: 2016-03-16
Granted: 2017-11-23
Abstract: A flowable, sustained release pharmaceutical composition for treating cerebral vasospasm in a human subject, the pharmaceutical composition comprising: a) a therapeutic amount of a therapeutic agent selected from the group consisting of a calcium channel antagonist, an endothelin (ET) receptor antagonist, a transient receptor potential (TRP) channel antagonist, and a combination thereof; and b) a pharmaceutically acceptable carrier, wherein the carrier comprises a plurality of particles, and wherein the therapeutic agent may be dispersed throughout each particle, adsorbed into the particles or contained by the particles in a core surrounded by a coating, wherein the pharmaceutical composition is formulated for local delivery so that it is capable of flowing around a cerebral artery at risk of vasospasm without entering the systemic circulation in an amount to cause unwanted side effects, and wherein the therapeutic amount is capable of producing a localized pharmacologic effect, wherein the therapeutic amount is effective to treat the cerebral vasospasm.
Patent AU-2016204840-B2 (AU)
Title: Improvements in or relating to packaging
Inventor: FRANIC IVICA
IPC: B65D5/06
Filed: 2016-07-11
Granted: 2018-03-15
Abstract: A carton and carton blank for forming a carton, and comprising a row of first, second, third and fourth substantially four-edged panels, each comprising a side wall part, a top closure obturating part and a top sealing fin part, one of said panels being 5 substantially free from any line of weakness extending inwardly from lateral edge zones of said one of said panels from an outermost boundary of the side wall part to an outermost boundary of the top sealing fin part.
Patent AU-2016204986-B2 (AU)
Title: Factor VIII Chimeric And Hybrid Polypeptides, And Methods Of Use Thereof
Inventor: LUK ALVIN
IPC: A61K38/37
Filed: 2016-07-15
Granted: 2018-05-10
Abstract: The present invention provides methods of administering Factor VIII (processed FVIII, single chain FVIII, or a combination thereof); methods of administering chimeric and hybrid polypeptides comprising Factor VIII; chimeric and hybrid polypeptides comprising Factor VIII; polynucleotides encoding such chimeric and hybrid polypeptides; cells comprising such polynucleotides; and methods of producing such chimeric and hybrid polypeptides using such cells.
Patent AU-2016208384-B2 (AU)
Title: Clostridium histolyticum enzymes and methods for the use thereof
Inventor: HERBER WAYNE K
IPC: C12N9/52
Filed: 2016-07-28
Granted: 2018-09-13
Abstract: The invention relates to recombinant nucleic acid and polypeptides encoding collagenase I and collagenase II, methods for the preparation thereof and methods for the use thereof. The present invention also provides a method for detecting the secretion of a haemolytic toxin by a bacterial production strain, wherein the production strain produces a collagenase, prior to therapeutic administration of said collagenase to a patient and methods for detecting the presence of a haemolytic toxin in a collagenase composition.
Patent AU-2016216737-B2 (AU)
Title: Voice Authentication and Speech Recognition System
Inventor: SUMMERFIELD CLIVE
IPC: G10L17/14
Filed: 2016-08-19
Granted: 2018-04-26
Abstract: A method for configuring a speech recognition system comprises obtaining a speech sample utilised by a voice authentication system in a voice authentication process. 5 The speech sample is processed to generate acoustic models for units of speech associated with the speech sample. The acoustic models are stored for subsequent use by the speech recognition system as part of a speech recognition process.
Patent AU-2016220153-B2 (AU)
Title: Therapeutic compounds
Inventor: HECHT SIDNEY
IPC: C07D239/47
Filed: 2016-02-17
Granted: 2020-07-02
Abstract: Compounds of formula (I) and salts are disclosed. Also disclosed are isotopes of compounds of formula I of the salts thereof. Pharmaceutical compositions comprising a compound of formula I, processes for preparing compounds of formula I, intermediates useful for preparing compounds of formula I and therapeutic methods using a compound of formula I are disclosed.
Patent AU-2016235022-B2 (AU)
Title: Tomato hybrid sv2756tm and parents thereof
Inventor: BUNN TERESA BECK
IPC: A01H5/08
Filed: 2016-09-30
Granted: 2020-11-05
Abstract: The invention provides seed and plants of tomato hybrid SV2756TM and the parent 
lines thereof. The invention thus relates to the plants, seeds and tissue cultures of tomato hybrid 
SV2756TM and the parent lines thereof, and to methods for producing a tomato plant produced 
by crossing such plants with themselves or with another tomato plant, such as a plant of another 
genotype. The invention further relates to seeds and plants produced by such crossing. The 
invention further relates to parts of such plants, including the fruit and gametes of such plants.
Patent AU-2016248388-B2 (AU)
Title: 5-aromatic alkynyl substituted benzamide compound and preparation method, pharmaceutical composition, and use thereof
Inventor: LIU HONG
IPC: C07D213/75
Filed: 2016-04-15
Granted: 2019-06-06
Abstract: The present invention relates to the fields of pharmaceutical chemistry and drug therapy, and particularly relates to a compound of formula I, and a preparation method and use thereof as a negative allosteric modulator of a metabotropic glutamate receptor (mGluR) subtype 5.
Patent AU-2016261354-B2 (AU)
Title: Pneumatically actuated air control devices and methods
Inventor: SMITH JEFFREY P
IPC: B62D37/02
Filed: 2016-05-06
Granted: 2020-12-24
Abstract: A pneumatically actuated air control device is provided. The device includes a control surface that affects the air flow along the device, and an at least one pneumatic motor configured to alter or change the configuration or orientation of the control surface or sections thereof. The device is configured such that when selective air pressure is supplied to the at least one motor, the control surface or sections thereof changes its configuration or its orientation with respect to the air flow, thereby affecting the air flow with respect to the device.
Patent AU-2016263309-B2 (AU)
Title: A highly concentrated powdered oleoresin composition and process for preparation thereof
Inventor: PARACHUR VIVEK ANAND
IPC: A61K36/00
Filed: 2016-05-14
Granted: 2021-09-02
Abstract: The invention disclosed herein is a highly concentrated powdered oleoresin composition comprises oleoresin(s), Mineral hydroxide(s)/ oxide(s)/ chloride(s)/ carbonate(s) and optionally comprises organic/inorganic acid(s); wherein said composition has enhanced stability and increased bioavailability. The invention also disclosed herein a process for preparation of said composition.
Patent AU-2016309833-B2 (AU)
Title: Pharmaceutical composition and application replacing quinolone derivative, pharmaceutical acceptable salt, or stereoisomer
Inventor: DING KE
IPC: C07D487/04
Filed: 2016-08-18
Granted: 2019-05-23
Abstract: Provided are a pharmaceutical composition, as indicated by Formula (I), and an application thereof in preparing a tumor prevention drug, replacing a quinolone derivative or a pharmaceutical acceptable salt, and a prodrug molecule. The quinolone derivative, salt, prodrug and pharmaceutical composition thereof can serve as a protein kinase inhibitor, effectively inhibiting AXL protein kinase activity and cell growth, migration and invasion of a plurality of tumor cells, and being applicable to preparing a tumor prevention drug, and specifically, to a drug treating an excessive proliferative disease such as a tumor for human being and other mammals.
Patent AU-2016318944-B2 (AU)
Title: System and method for powering a device used in conjunction with a wet cell battery
Inventor: CAMPAU DANIEL N
IPC: G01F23/24
Filed: 2016-09-08
Granted: 2019-02-14
Abstract: The specification discloses a system and a method for powering electrical devices using the voltage difference between the cells of a wet cell battery. The system includes probes inserted into the electrolyte in different cells of the battery. The probes are electrically connected to the devices to power the devices. The probes, the devices, and/or the connecting wires may be incorporated into, or otherwise installed with, vent caps or single-point watering systems.
Patent AU-2016321400-B2 (AU)
Title: System and method for systemic detection of display errors
Inventor: DUNN WILLIAM
IPC: G06F3/00
Filed: 2016-09-12
Granted: 2019-05-30
Abstract: A system and method for systemically addressing failures in electronic displays without user interaction comprises an electronic display connected to a timing and control board, connected to a system control board having a network interface component with a power button. A video player is connected to the system control board and has a video player power button. The system control board may simulate pushing the power button, the video power button, and/or disrupting the power supply to the video player if the video player is not communicating.
Patent AU-2016330300-B2 (AU)
Title: Method for determining diagnostic models for time series of a technical system and diagnostic method
Inventor: GRIMM STEPHAN
IPC: G05B23/02
Filed: 2016-09-23
Granted: 2019-07-18
Abstract: The invention relates to a method for determining diagnostic models for time series of a technical system and to a diagnostic method. In the method for determining one or more diagnostic model/s for time series of a technical system for the purpose of diagnosing an event, firstly, one or more diagnostic models are formulated and, in a first step, possible extensions of the diagnostic model/s are determined; in a second step, for each extension of the/each diagnostic model/s, a set of sequences is determined from the time series, in which the extension is contained; in a third step, each sequence of said set is tested to determine whether the sequence is connected with the event; and in a fourth step, the/those extension/s for which the ratio of the number of sequences of the set which are connected with the event to the number of sequences of the set is largest, is/are set as the new diagnostic model.
Patent AU-2016337175-B2 (AU)
Title: Method and device for mobile magnetic measurements for controlling the magnetic signature of a vessel
Inventor: PERIOU JEAN-JACQUES
IPC: G06F17/10
Filed: 2016-10-13
Granted: 2022-07-07
Abstract: The invention relates to the measurement and control of a magnetic signature of a vessel by means of an autonomous mobile device provided with a magnetic sensor. After having obtained (310) magnetic measurements and the corresponding positions, a magnetisation of the vessel is modelled (325) and then a magnetic field is calculated according to the modelling of the magnetisation of the vessel and navigation parameters. A system for reducing the magnetic signature of the vessel is then controlled (335) according to the estimated magnetic field.